Dr. Church is a pioneer in the field of personal genetics and synthetic biology. His keynote presentation will take place on the first day of the 2019 Genetics & Genomics Virtual Conference, on May 8, 2019 at 7:30 AM PDT and it will be focused on Interpreting the Zero Dollar Genome via Base Editing, Organoids & in Situ Omics. Church is the director of PersonalGenomes.org, the world's only open-access information on human genomic, environmental, and trait data. He is also the director of IARPA & NIH BRAIN Projects and National Institutes of Health Center for Excellence in Genomic Science and is a founding core member of the Wyss Institute for Biologically Inspired Engineering. Currently, Church is spearheading efforts on bringing back the woolly mammoth through genetic engineering at a lab at Harvard Medical School.
Church has played an important role in helping determine the three-dimensional structure of transfer RNA, a key genetic molecule, and helping develop DNA sequencing, which then led to dramatic cost reductions. Church and his team invented CRISPR for human stem cell genome editing and other synthetic biology technologies and applications. Now, his laboratory's use of CRISPR in human induced pluripotent stem cells (hiPS) is the latest contender for precise gene therapy. Dr. Church has also contributed to the Human Genome Project and he co-initiated the BRAIN Initiative (2011). He has co-authored hundreds of scientific papers, patent publication, and the book, "Regenesis." He has received numerous awards including the Franklin Bower Laureate for Achievement in Science and election to the National Academies of Sciences and Engineering. Dr. George Church's innovations have been instrumental in nearly all "next-generation DNA sequencing methods" and are key in today's ongoing research.
Dr. Snyder is an international leader in the fields of functional genomics and proteomics and one of the major contributors of the ENCODE project. His keynote presentation will be on Big Data and Health and will take place on May 9, 2019 at 7:30 AM PDT. Snyder's research group was the first to perform a large-scale functional genomics project in any organism and has developed many technologies in genomics and proteomics. These include the development of proteome chips, methods for global mapping of transcription factor binding sites (ChIP-chip now replaced by ChIP-seq), and RNA-Seq to name a few. These technologies have been used for characterizing genomes, proteomes and regulatory networks.
Snyder is a cofounder of several biotechnology companies, including Protometrix, Affomix, Excelix, Personalis and founder of Qbio, and he presently serves on the board of a number of companies. He is also the author of the book, "Genomics and Personalized Medicine: What Everyone Needs to Know." Dr. Snyder and his lab have made several groundbreaking findings and advances in human genome research and continue to do so today.
For more information or to register for the event, click here.
About LabRoots
LabRoots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. We have become a primary source for trending scientific news, webinars, virtual conferences and more. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.
© Copy Right 2019 Jessica Brown's Press Releases.
All information are taken from the news source. We do not promise anything nor take any responsibility for anything the news owner claim. We just share the news as is. You can contact news owner directly in the message for more information.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.